BIFOSFONATOS EN ODONTOLOGIA PDF

Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.

Author: Voodoolkree Dushura
Country: Bangladesh
Language: English (Spanish)
Genre: Video
Published (Last): 24 December 2004
Pages: 217
PDF File Size: 11.14 Mb
ePub File Size: 15.34 Mb
ISBN: 258-9-64976-180-3
Downloads: 88795
Price: Free* [*Free Regsitration Required]
Uploader: JoJosar

Alendronate in the treatment of primary hyperparathyroidrelated osteoporosis: The treatment of renal lithiasis with biphosphonates.

Sin embargo, sigue existiendo una considerable incertidumbre en cuanto a la evidencia global. Bisphosphonates and osteonecrosis of the jaws: Removal of necrotic bone is recommended in severe cases.

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

La eficacia demostrada de tratamientos con dosis oral de 70 mg de alendronato una vez por semana 11 puede facilitar el cumplimiento del tratamiento. J Clin Oncol ; Oncologist, 12pp.

  100 COLPI DI SPAZZOLA LIBRO PDF

Osteonecrosis of the jaws and bisphosphonates Report of three cases. Probably the origin of the osteonecrosis of the jaws is a decreased microcirculation and a limited bone turnover due to bisphosphonates, leading to diminish their healing capacity and regeneration of the tissues. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: Bisphosphonate-associated osteonecrosis of the jaw: The purpose of this review is to describe the characteristics of bisphosphonates, its mechanism of action, clinical manifestation of osteonecrosis of the jaws, therapeutic management and prevention.

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Reports of esophageal cancer with oral bisphosphonate use.

Rev Osteoporos Metab Miner ; 1 1: Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Med Clin Barc ; Osteonecrosis of the jaws bifpsfonatos with the use of bisphosphonates: Osteonecrosis of the jaw, a recently recognized sequela of bisphosphonate therapy: Dent Today ; Low-energy femoral shaft fractures associated with alendronate use. The management of the lesions is difficult.

Tratamiento de la litiasis renal con bifosfonatos

Bisphosphanates and oral cavity avascular bone necrosis. N Engl J Med,pp. Otros estudio, que utilizaba la misma base de datos que el de Green y cols. No se pueden establecer conclusiones definitivas, debido fundamentalmente a la escasez de estudios y heterogeneidad de los mismos. Tratamiento de la hipercalcemia con bifosfonatos. Adverse effects of bisphosphonates. The actuality of a higher risk for esophageal cancer in association with the use of bisphosphonates could not be confirmed.

  ETY RAPAPORT PDF

Revista Clínica de Periodoncia, Implantología y Rehabilitación Oral

J Orthop Sci, 12pp. IARC Scientific publications number Primer on the metabolic bone diseases ad disorders of mineral metabolism, pag. Implants and oral bisphosphonates: Se han propuesto algunas recomendaciones para bifosfonwtos manejo de los pacientes tratados con bifosfonatos que presentan efectos adversos oculares Tabla II.

Hematol Oncol en prensa. However, the FDA recommends that oral bisphosphonates should not be prescribed for patients with Barrett’s esophagus. Osteonecrosis of the jaws: